CIK 0001528287
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
NeuroPace Inc
Sign in to watch- Ticker
- NPCE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 223550230
- Phone
- +1 650-237-2700
- Business address
- 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | Kuhn Rebecca Chief Financial Officer | Grant or award | +46,740 | 58,276 | ||
| 2022-03-03 | Kuhn Rebecca Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +93,480 | 93,480 | ||
| 2022-03-03 | Morrell Martha Chief Medical Officer | Grant or award | +46,760 | 56,588 | ||
| 2022-03-03 | Morrell Martha Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +93,530 | 93,530 | ||
| 2022-02-28 | Ridley Irina General Counsel and Secretary | Sale | −1,470 | $7.54 | $11K | 6,652 |
| 2021-11-01 | Andrade Lisa Director | Grant or award · Stock Option (Right to Buy) | +11,836 | 11,836 | ||
| 2021-06-04 | Favet Michael Chief Executive Officer | Grant or award | +27,000 | 27,000 | ||
| 2021-06-04 | Favet Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2021-06-04 | Morrell Martha Chief Medical officer | Grant or award | +8,310 | 9,828 | ||
| 2021-06-04 | Morrell Martha Chief Medical officer | Grant or award · Stock Option (Right to Buy) | +16,620 | 16,620 | ||
| 2021-06-04 | Kuhn Rebecca Chief Financial Officer | Grant or award | +8,310 | 11,536 | ||
| 2021-06-04 | Kuhn Rebecca Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,620 | 16,620 | ||
| 2021-06-04 | Ridley Irina General Counsel and Secretary | Grant or award | +5,770 | 8,122 | ||
| 2021-06-04 | Ridley Irina General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +11,540 | 11,540 | ||
| 2021-06-04 | Morrell Martha Chief Medical officer | Grant or award | +8,181 | 9,699 | ||
| 2021-06-04 | Morrell Martha Chief Medical officer | Grant or award · Stock Option (Right to Buy) | +16,363 | 16,363 | ||
| 2021-06-04 | Favet Michael Chief Executive Officer | Grant or award | +26,590 | 26,590 | ||
| 2021-06-04 | Favet Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +53,180 | 53,180 | ||
| 2021-06-04 | Kuhn Rebecca Chief Financial Officer | Grant or award | +8,181 | 11,407 | ||
| 2021-06-04 | Kuhn Rebecca Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +16,363 | 16,363 |
Page 16 of 19 · 362 trades